Antitumor agent-169
Product Specifications
UNSPSC Description
Antitumor agent-169 (Compound B3) is a dual inhibitor PD-1/PD-L1 interaction and PARP7, with IC50s of 0.426 μM and 2.50 nM. Antitumor agent-169 exhibits an affinity to human PD-L1, with Ki of 20.2 nM. Antitumor agent-169 restores the T cell function, increases IFN-γ secretion. Antitumor agent-169 inhibits cell viability of MDA-MB-231 and Jurkat T, exhibits antitumor efficacy against melanoma in mouse model and good pharmacokinetic characteristics[1].
Target Antigen
PARP; PD-1/PD-L1
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage;Epigenetics;Immunology/Inflammation
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/antitumor-agent-169.html
Smiles
CC1=C(C=CC=C1C2=CC=CC=C2)COC3=CC(OC)=C(C(OC)=C3)CN4CCCC[C@H]4C(NCCOCCOCCNC(C5=CN=C(N=C5)N6CCN(CC6)C(CCOC[C@@H](NC7=C(C(NN=C7)=O)C(F)(F)F)C)=O)=O)=O
Molecular Weight
1087.19
References & Citations
[1]Gao Y, et al., Novel Bifunctional Conjugates Targeting PD-L1/PARP7 as Dual Immunotherapy for Potential Cancer Treatment. J Med Chem. 2024 Jun 24.
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-162643/Antitumor-agent-169-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-162643/
Clinical Information
No Development Reported
CAS Number
9007-83-4
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
RPG159Hu01-03 100 µg
Recombinant Ubiquitin Like Modifier Activating Enzyme 3 (UBA3)
Ask
View Details 
RPG159Hu01-04 200 µg
Recombinant Ubiquitin Like Modifier Activating Enzyme 3 (UBA3)
Ask
View Details RPG159Hu01-05 500 µg
Recombinant Ubiquitin Like Modifier Activating Enzyme 3 (UBA3)
Ask
View Details